CFS Clinical Trial - Frailty in Critical Care Unit's Patients

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03952624` - Patient-Centered Assessment of Symptoms and Outcomes
Recruiting	`NCT04599348` - Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng	Early Phase 1
Recruiting	`NCT04598243` - Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract	Early Phase 1
Completed	`NCT04877028` - Frailty Screening in the Swedish Emergency Department Setting

See also

Status

Clinical Trial

Phase

Recruiting

NCT03952624 - Patient-Centered Assessment of Symptoms and Outcomes

Recruiting

NCT04599348 - Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng

Early Phase 1

Recruiting

NCT04598243 - Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract

Early Phase 1

Completed

NCT04877028 - Frailty Screening in the Swedish Emergency Department Setting

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06117462
Study type	Observational
Source	Assiut University
Contact	Doaa Mostafa Ibrahim
Phone	01141896238
Email	doaamostafa299@gmail.com
Status	Not yet recruiting
Phase
Start date	December 2023
Completion date	December 2024

Frailty in Critical Care Unit's Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms